Global Human Herpersvirus 5 (HHV-5) Drug Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 17157

In 2018, the global Human Herpersvirus 5 (HHV-5) Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Human Herpersvirus 5 (HHV-5) Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Herpersvirus 5 (HHV-5) Drug development in United States, Europe and China.

The key players covered in this study
Roche
Livzon Pharmaceuticals
Sichuan Cologne Pharmaceutical
Hubei Branch benefits medicine
GlaxoSmithKline
Upright and clear
Chongqing Winbond (acquisition of Sichuan Mingxin)
Haikou Kellett
On the drug new Asia
Chongqing Fu'an Pharmaceutical
Shandong Luo Xin Pharmaceutical
Yangtze River Pharmaceutical
Qianjiang Pharmaceuticals
Wuhan Hualong

Market segment by Type, the product can be split into
Ganciclovir
Valerian Gilivir Drugs
Acyclovir Drugs
Valacyclovir Drugs
Foscarnet Sodium Drugs

Market segment by Application, split into
Immunodeficiency Crowd
Organ Transplant Crowd
CMV Herpes Crowd

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Herpersvirus 5 (HHV-5) Drug status, future forecast, growth opportunity, key market and key players.
To present the Human Herpersvirus 5 (HHV-5) Drug development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Herpersvirus 5 (HHV-5) Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Ganciclovir
1.4.3 Valerian Gilivir Drugs
1.4.4 Acyclovir Drugs
1.4.5 Valacyclovir Drugs
1.4.6 Foscarnet Sodium Drugs
1.5 Market by Application
1.5.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Application (2014-2025)
1.5.2 Immunodeficiency Crowd
1.5.3 Organ Transplant Crowd
1.5.4 CMV Herpes Crowd
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human Herpersvirus 5 (HHV-5) Drug Market Size
2.2 Human Herpersvirus 5 (HHV-5) Drug Growth Trends by Regions
2.2.1 Human Herpersvirus 5 (HHV-5) Drug Market Size by Regions (2014-2025)
2.2.2 Human Herpersvirus 5 (HHV-5) Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Human Herpersvirus 5 (HHV-5) Drug Market Size by Manufacturers
3.1.1 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Concentration Ratio (CR5 and HHI)
3.2 Human Herpersvirus 5 (HHV-5) Drug Key Players Head office and Area Served
3.3 Key Players Human Herpersvirus 5 (HHV-5) Drug Product/Solution/Service
3.4 Date of Enter into Human Herpersvirus 5 (HHV-5) Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type (2014-2019)
4.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application (2014-2019)

5 United States
5.1 United States Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
5.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in United States
5.3 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
5.4 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

6 Europe
6.1 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
6.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Europe
6.3 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
6.4 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

7 China
7.1 China Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
7.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in China
7.3 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
7.4 China Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

8 Japan
8.1 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
8.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Japan
8.3 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
8.4 Japan Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
9.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Southeast Asia
9.3 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
9.4 Southeast Asia Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

10 India
10.1 India Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
10.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in India
10.3 India Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
10.4 India Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

11 Central & South America
11.1 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size (2014-2019)
11.2 Human Herpersvirus 5 (HHV-5) Drug Key Players in Central & South America
11.3 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
11.4 Central & South America Human Herpersvirus 5 (HHV-5) Drug Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.1.4 Roche Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Livzon Pharmaceuticals
12.2.1 Livzon Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.2.4 Livzon Pharmaceuticals Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.2.5 Livzon Pharmaceuticals Recent Development
12.3 Sichuan Cologne Pharmaceutical
12.3.1 Sichuan Cologne Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.3.4 Sichuan Cologne Pharmaceutical Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.3.5 Sichuan Cologne Pharmaceutical Recent Development
12.4 Hubei Branch benefits medicine
12.4.1 Hubei Branch benefits medicine Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.4.4 Hubei Branch benefits medicine Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.4.5 Hubei Branch benefits medicine Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.5.4 GlaxoSmithKline Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Upright and clear
12.6.1 Upright and clear Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.6.4 Upright and clear Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.6.5 Upright and clear Recent Development
12.7 Chongqing Winbond (acquisition of Sichuan Mingxin)
12.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.7.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
12.8 Haikou Kellett
12.8.1 Haikou Kellett Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.8.4 Haikou Kellett Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.8.5 Haikou Kellett Recent Development
12.9 On the drug new Asia
12.9.1 On the drug new Asia Company Details
12.9.2 Company Description and Business Overview
12.9.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.9.4 On the drug new Asia Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.9.5 On the drug new Asia Recent Development
12.10 Chongqing Fu'an Pharmaceutical
12.10.1 Chongqing Fu'an Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Human Herpersvirus 5 (HHV-5) Drug Introduction
12.10.4 Chongqing Fu'an Pharmaceutical Revenue in Human Herpersvirus 5 (HHV-5) Drug Business (2014-2019)
12.10.5 Chongqing Fu'an Pharmaceutical Recent Development
12.11 Shandong Luo Xin Pharmaceutical
12.12 Yangtze River Pharmaceutical
12.13 Qianjiang Pharmaceuticals
12.14 Wuhan Hualong

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details